Comparison of Never Performing Episiotomy to Performing it in a Selective Manor (EPISIO)

November 16, 2016 updated by: Leila Katz, Instituto Materno Infantil Prof. Fernando Figueira

Not Performing Episiotomy Versus Selective Episiotomy: a Randomized Clinical Trial

The study hypothesis is that not performing never episiotomies is safe and results are equivalent to performing episiotomies ina selective manor.

Study Overview

Status

Completed

Conditions

Detailed Description

World Health Organization recommends that the rate of episiotomy in various departments will be around 10%, which is already a reality in many European countries. The episiotomy should be limited and physicians should be encouraged to use their clinical judgment to decide when the procedure is necessary. There are no clinical evidence corroborating any indication of episiotomy, so not yet known whether episiotomy is indeed necessary in any context obstetric practice. Objectives: To compare the maternal and perinatal outcomes in women undergoing a protocol of not conducting episiotomy versus selective episiotomy. Methods: A randomized clinical trial will be conducted in open Maternity Instituto de Medicina Integral Prof. Fernando Figueira, from August 2012 to July 2013. 340 women will be included in labor with term pregnancy, maximum dilation of 8 cm, live fetus in cephalic vertex presentation and will be excluded women with bleeding disorders of pregnancy , indication for caesarean section, women without capacity to consent and without legal guardians. The primary outcomes will be: frequency of episiotomy, delivery duration, frequency of spontaneous lacerations, frequency of instrumental delivery. frequency of perineal trauma, postpartum blood loss, need for perineal suturing, number of sutures, Apgar scores at one and five minutes, need for neonatal resuscitation and pH in cord blood. As secondary outcomes will be assessed: frequency of severe perineal trauma, complications of perineal suturing perineal pain postpartum evaluated according to the visual scale, maternal satisfaction, neonatal morbidity and admission RN in NICU. Women will be invited to participate and those who agree should signing the consent form. At the beginning of the second stage will open the envelope to determine which group included women, with 170 assigned to a protocol of not conducting episiotomy (experimental group) and 170 to a group that episiotomy is performed selectively (Control Group ), according to the judgment of the provider of care delivery. Statistical analysis will be performed using the Epi-Info statistical program 7, adopting the principle of intention to treat. The analysis will be performed with the groups identified as A or B by a blinded statistician to the meaning of the lyrics, breaking the secrecy only after the results obtained and prepared the tables. Categorical variables were compared in contingency tables, using the chi-square test of association and Fisher's exact test, as appropriate. The risk ratio (RR) shall be calculated as measure of relative risk, determining the confidence interval at 95%. Regarding the quantitative variables, if they have normal distribution, comparison between groups will be conducted through the Student's t test for unpaired samples. If it is found that the distribution is not normal, the nonparametric Mann-Whitney-will be used. Ethical aspects, the present study addresses the Resolution 196/96 of the National Health Council and will be submitted to the iMIP Research Ethics Committee, beginning only after your approval. All participants will be included only if they agree to voluntarily participate by signing the consent

Study Type

Interventional

Enrollment (Actual)

237

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pernambuco
      • Recife, Pernambuco, Brazil, 50070-550
        • IMIP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women in active labor admitted to the maternity ward
  • Term pregnancy (37-42 weeks gestation);
  • Maximum Dilation 8cm;
  • Live fetus in vertex position.

Exclusion Criteria:

  • hemorrhagic syndromes of pregnancy (premature separation of the normally implanted placenta
  • Women with an indication for cesarean section: cephalopelvic disproportion (DCP), non reassuring fetal heart rate, dystocia;
  • Women without capacity to consent and without legal guardians.
  • Women undergoing cesarean delivery (post-randomization exclusion)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Never perform episiotomy
In this group the birth attendant will sought to avoid the use of episiotomy, and try not to carry out the procedure unless considered absolutely needed
In this group birth attendants will be sought to avoid at all cost episiotomy. The intention is to never perform episiotomy in this group.
ACTIVE_COMPARATOR: Selective episiotomy
Patients will be subjected to the usual routine (selective episiotomy, ie, in the presence of indications described in the literature, according to the discretion of the physician or nurse assisting the birth)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
duration of the second stage of labor
Time Frame: From beginning of second stage of labor to delivery of the baby
Time in minutes from beginning of second stage of labor until the delivery of the baby
From beginning of second stage of labor to delivery of the baby
frequency of episiotomy
Time Frame: From diagnosis of second stage of labor to delivery of the neonate
Frequency of episiotomies in fact carried out
From diagnosis of second stage of labor to delivery of the neonate
frequency of spontaneous lacerations
Time Frame: From randomizatyion to one hour after delivery
Frequency of spontaneous lacerations verified immediatly after delivery (time frame from randomization until one hour after delivery)
From randomizatyion to one hour after delivery
blood loss at delivery
Time Frame: from delivery to one hour postpartum
Volume of blood loss in mililiters, lost by the patient from the genital tract, from the moment of the delivery to one hour after delivery
from delivery to one hour postpartum
perineal need of suturing
Time Frame: From delivery to one hour postpartum
Perineal suturing carried out by the birth attendant
From delivery to one hour postpartum
Apgar scores
Time Frame: From delivery to five minutes after delivery
one and five minutes Apgar scores
From delivery to five minutes after delivery
need for neonatal resuscitation
Time Frame: From delivery to one hour after delivery
Need of any resuscitation procedures carried out in the conduction of the neonate, from the time of birth until one hour after delivery
From delivery to one hour after delivery
cord blood pH at birth
Time Frame: From birth of the baby until first minute after delivery
Cord blood pH ( hydrogen ion concentration) at birth collected just after delivery
From birth of the baby until first minute after delivery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
frequency of severe perineal trauma
Time Frame: from delivery of the baby until one hour after delivery
frequency of severe perineal trauma observed by the birth attendant
from delivery of the baby until one hour after delivery
complications of perineal suture
Time Frame: From delivery until 15 days after delivery
presence of hematoma, or infection or dehiscence of perineal suture described in the patients records from the moment of the delivery until 15 days after the delivery
From delivery until 15 days after delivery
perineal pain after childbirth
Time Frame: From 24 hours after delivery until 48 hours of the delivery
perineal pain after childbirth evaluated according to the visual scale and maternal satisfaction, the evaluation is carried from 24 to 48 hours after the delivery, before maternal discharge from the hospital
From 24 hours after delivery until 48 hours of the delivery
admission of the newborn (NB) in the neonatal intensive care unit (ICU).
Time Frame: from delivery until 28 days after birth
admission of the newborn (NB) in the neonatal intensive care unit (ICU).
from delivery until 28 days after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Inês Melo, MS, IMIP

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (ACTUAL)

September 1, 2014

Study Completion (ACTUAL)

September 1, 2014

Study Registration Dates

First Submitted

June 16, 2014

First Submitted That Met QC Criteria

June 26, 2014

First Posted (ESTIMATE)

June 30, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

November 17, 2016

Last Update Submitted That Met QC Criteria

November 16, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • EPISIO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Need of Episiotomy

Clinical Trials on Never perform episiotomy

3
Subscribe